Late-stage functionalization of the 4-amino-2-pyridone chemotype using electrochemical and MCR approaches
We report the development and application of different strategies for the late-stage functionalization (LSF) of the biologically relevant 4-amino-2-pyridone chemotype. Using the recently discovered PCSK9 inhibitor 5c as a prototype, a series of electrochemical LSF (e-LSF) and multicomponent LSF (MCR...
Saved in:
Published in | Chemical communications (Cambridge, England) |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
14.08.2024
|
Online Access | Get full text |
Cover
Loading…
Summary: | We report the development and application of different strategies for the late-stage functionalization (LSF) of the biologically relevant 4-amino-2-pyridone chemotype. Using the recently discovered PCSK9 inhibitor 5c as a prototype, a series of electrochemical LSF (e-LSF) and multicomponent LSF (MCR-LSF) have been set-up to decorate the 4-amino-2-pyridone scaffold. The usefulness of these methods has been demonstrated by generating a series of novel derivatives in a site-selective and sustainable way. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1359-7345 1364-548X 1364-548X |
DOI: | 10.1039/D4CC02473G |